Broad Market

(redirected from Broader Markets)

Broad Market

Usually refers to indices such as the Wilshire 5000 that track the performance of 5,000 securities, rather than the more narrow measures such as the Dow Jones Industrial Average and the S&P 500.

Broad Market

An index that consists of many stocks or stocks in many different industries. Broad market indices are not terribly useful in gauging the performance of individual industries they help give an indication of movements in the broader economy. An example of a broad market is the Wilshire 5000. See also: Narrow market.
References in periodicals archive ?
Wyman-Gordon Forgings continues to increase its capabilities to meet a broader spectrum of its current customers' requirements and to extend its reach into broader markets," said PCC Chairman and CEO William C.
The broader markets were weak on Friday," said William McKinley, President of Investing Systems.
Savient Pharmaceuticals is a biopharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that target unmet medical needs in both niche and broader markets.
Savient Pharmaceuticals is a specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in both niche and broader markets.
is a specialty pharmaceuticals company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in both niche and broader markets.
When the broader markets are falling there are always isolated stocks making big gains," McKinley said.
is a specialty pharmaceuticals company and is engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in both niche and broader markets.
is an emerging specialty pharmaceuticals company and is engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in both niche and broader markets.
in which CLX holds a 31 percent equity interest, is expanding the distribution of its product lines into broader markets around the world, beginning with new European markets.
NASDAQ:SVNTE) an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in niche and broader markets, today announced the closing of the sale of its Delatestryl(R) product to Indevus Pharmaceuticals, Inc.
Savient") (NASDAQ: SVNTE), an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in niche and broader markets, announced today that it has concluded with Barr Pharmaceuticals, Inc.
As we further expand our presence across broader markets and reinforce our leadership position in Enterprise Contract Management, we require an experienced and pro-active investor relations firm to help support this mission.